Daewoong pharmaceutical Co.,Ltd
KSC: 069620.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chang-Jae Lee
- Employees
- 1,727
- Headquarters
- Seoul, South Korea
- IPO year
- 2005
- Market cap
- ₩1.7T
- Website
- https://www.daewoong.com
Loading 069620…
Loading profile data…Frequently asked questions about 069620
What does Daewoong pharmaceutical Co.,Ltd (069620.KS) do?
Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive disease...
Where does 069620.KS trade?
Daewoong pharmaceutical Co.,Ltd (069620.KS) trades on the Korea Exchange.
What sector is 069620.KS in?
Daewoong pharmaceutical Co.,Ltd (069620.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Daewoong pharmaceutical Co.,Ltd?
Chang-Jae Lee is the chief executive officer of Daewoong pharmaceutical Co.,Ltd (069620.KS).
Where is Daewoong pharmaceutical Co.,Ltd headquartered?
Daewoong pharmaceutical Co.,Ltd is headquartered in South Korea.
Does 069620.KS pay a dividend?
Yes — Daewoong pharmaceutical Co.,Ltd (069620.KS) paid a trailing twelve-month dividend of KRW 600.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 069620.KS go public?
Daewoong pharmaceutical Co.,Ltd (069620.KS) completed its initial public offering in 2005.